John Valliant wins Life Science Company of the Year Award
A McMaster spin-off company won the Life Sciences Company of the Year award. Fusion’s CEO, John Valliant, Canada Research Chair in Medical Isotopes and Molecular Imaging Probes, and Professor, Chemistry &Chemical Biology, accepted the Life Sciences Company of the Year award presented by Life Sciences Ontario at a gala event honouring leaders in the province’s life sciences sector. Read more about it here in The Daily News.
Related News
News Listing
La Fondation de la Maison de la Chimie ➚
Prof. Schrobilgen Awarded 2024 International Henri Moissan Prize
Uncategorized
April 1, 2024
McMaster Daily News ➚
AstraZeneca moves to acquire Dr. Valliant founded Fusion Pharmaceuticals for $2.4 billion (US)
Uncategorized
March 21, 2024